ANTHRONE DERIVATIVES AND THEIR USE AS JNK INHIBITORS - Patent 1363891

(19)

(11)

EP 1 363 891 A2

(12)

(88)	Date of publication A3:
	05.12.2002

(43)	Date of publication:
	26.11.2003 Bulletin 2003/48

(21)	Application number: 02720975.8

(22)	Date of filing: 13.02.2002

(51)	International Patent Classification (IPC)⁷: C07D 275/04, A61K 31/425, A61P 43/00, C07D 417/12

(86)	International application number:
	PCT/US0204/283

(87)	International publication number:
	WO 0206/6450 (29.08.2002 Gazette 2002/35)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

15.02.2001 US 269013 P
07.02.2002 US 71390

(71)	Applicant: SIGNAL PHARMACEUTICALS, INC.
	San Diego, CA 92121 (US)

(72)	Inventors:
	SAKATA, Steven, T. San Diego, CA 92130 (US) RAYMON, Heather, K. San Diego, CA 92117 (US)

(74)	Representative: Jump, Timothy John Simon et al
	Venner Shipley & Co.20 Little Britain London EC1A 7DH London EC1A 7DH (GB)

(54)	ANTHRONE DERIVATIVES AND THEIR USE AS JNK INHIBITORS